Anti-Cancer Drugs Grenader, T, Pavel, M E, Ruszniewski, P B, Ćwikła, J, Phan, A T, Raderer, M, Sedláčková, E, Cadiot, G, Wolin, E M, Capdevila, J, Wall, L, Rindi, G, Thanh, X M T, Caplin, M E & CLARINET Study Group 2020, ' Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors ', Anti-Cancer Drugs, vol. 31, no. 3, pp. 216-222 . https://doi.org/10.1097/CAD.0000000000000909 Scientia
British Journal of Cancer Corrie, P G, Qian, W, Basu, B, Valle, J, Falk, S, Iwuji, C, Wasan, H, Palmer, D, Scott-Brown, M, Wadsley, J, Arif, S, Bridgewater, J, Propper, D, Gillmore, R, Gopinathan, A, Skells, R, Bundi, P, Brais, R, Dalchau, K, Bax, L, Chhabra, A, Machin, A, Dayim, A, McAdam, K, Cummins, S, Wall, L, Ellis, R, Anthoney, A, Evans, J, Ma, Y T, Isherwood, C, Neesse, A, Tuveson, D & Jodrell, D I 2020, ' Scheduling nab-paclitaxel combined with gemcitabine as first line treatment for metastatic pancreatic adenocarcinoma ', BJC, vol. 122, pp. 1760–1768 . https://doi.org/10.1038/s41416-020-0846-2